ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 64 filers reported holding ERASCA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,608 | -0.9% | 40,410 | +38.8% | 0.00% | – |
| Q2 2023 | $80,333 | +113.7% | 29,106 | +124.5% | 0.00% | – |
| Q1 2023 | $37,593 | -98.4% | 12,963 | -95.8% | 0.00% | -100.0% |
| Q3 2022 | $2,391,000 | +41.4% | 306,540 | +1.0% | 0.00% | +100.0% |
| Q2 2022 | $1,691,000 | -35.1% | 303,537 | +0.1% | 0.00% | -50.0% |
| Q1 2022 | $2,607,000 | -44.8% | 303,174 | +0.0% | 0.00% | -33.3% |
| Q4 2021 | $4,721,000 | -24.1% | 303,055 | +3.4% | 0.00% | -25.0% |
| Q3 2021 | $6,221,000 | – | 293,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |